Skip to main content
FinSpry Logo
FinSpry
KNSA logo
KNSA
(NASDAQ)
Kiniksa Pharmaceuticals International, plc
$48.82-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Kiniksa Pharmaceuticals International (KNSA) Stock Price & Financial Analysis

Kiniksa Pharmaceuticals International Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$46.82 - $48.85
52-Week High$49.33
52-Week Low$18.26
Open$47.75
Volume435.52K
Average Volume (3M)435.52K
Market Cap3.86B
Shares Outstanding78.98M
P/E Ratio (TTM)64.42
Price to Sales (P/S)5.61
Price to Book (P/B)6.70
EV/EBITDA44.30
Revenue (TTM)677.56M
Net Income (TTM)59.01M
Free Cash Flow (TTM)136.42M
EPS (TTM)$0.75
Profit Margin8.71%
Operating Margin11.40%
Return on Equity (ROE)10.40%
Debt to Equity0.02
50-Day MA$45.20
200-Day MA$38.40
52-Week Change121.08%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Kiniksa Pharmaceuticals International

What is the current stock price for KNSA?

As of the latest trading session, KNSA stock trades at $48.82. The 52-week range is $18.26–$49.33, with a day range of $46.82–$48.85.

What is the P/E ratio for KNSA?

Kiniksa Pharmaceuticals International's trailing P/E ratio is 64.4, meaning investors pay $64.4 for every $1 of annual earnings. Kiniksa Pharmaceuticals International operates in the Healthcare sector.

Does KNSA pay dividends?

Kiniksa Pharmaceuticals International does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KNSA?

Based on 3 analysts, the consensus for KNSA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KNSA?

Kiniksa Pharmaceuticals International's market capitalization is $3.86B, classifying it as a mid-cap company. Kiniksa Pharmaceuticals International operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.